Aligned Genetics, Inc. (KOSDAQ:238120)
South Korea · Delayed Price · Currency is KRW 3,355.00
-45.00 (-1.32%)
At close: Oct 10, 2025
Aligned Genetics Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 3,317 | 4,128 | 3,236 | 2,333 | 5,542 | 468.23 | Upgrade |
Depreciation & Amortization | 555.57 | 575.74 | 631.38 | 650.38 | 538.59 | 676.07 | Upgrade |
Loss (Gain) From Sale of Assets | 0 | - | -4.5 | - | -13.94 | - | Upgrade |
Loss (Gain) From Sale of Investments | 7.44 | 7.44 | -34.04 | 591.23 | -1,686 | -944.36 | Upgrade |
Loss (Gain) on Equity Investments | -0 | 29.26 | 181.79 | -80.52 | 178.96 | 79.28 | Upgrade |
Provision & Write-off of Bad Debts | 7.78 | -2.79 | -0.55 | -11.88 | 2.97 | 20.04 | Upgrade |
Other Operating Activities | 457.92 | -739.87 | 487.38 | 417.53 | 99.1 | 683.89 | Upgrade |
Change in Accounts Receivable | 87.45 | 82.54 | -1,214 | 717.6 | -2,025 | -371.67 | Upgrade |
Change in Inventory | -188.77 | -119.94 | -55.66 | -1,407 | -337.39 | -101.87 | Upgrade |
Change in Accounts Payable | 135.22 | -219.98 | 14.31 | -53.19 | 1,017 | 161.57 | Upgrade |
Change in Unearned Revenue | -9.06 | -18.91 | 9.86 | - | - | - | Upgrade |
Change in Other Net Operating Assets | -755.41 | -699.56 | -452.6 | -1,084 | -1,409 | -635.5 | Upgrade |
Operating Cash Flow | 3,612 | 3,065 | 2,849 | 2,222 | 135.97 | 35.67 | Upgrade |
Operating Cash Flow Growth | 46.58% | 7.61% | 28.18% | 1534.52% | 281.17% | -94.59% | Upgrade |
Capital Expenditures | -492.85 | -257.69 | -878.54 | -2,001 | -3,307 | -96.43 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 12.98 | - | 32.25 | - | Upgrade |
Sale (Purchase) of Intangibles | -159.42 | -145.75 | -1.87 | -2.23 | - | -9.07 | Upgrade |
Sale (Purchase) of Real Estate | - | - | - | - | -1,557 | - | Upgrade |
Investment in Securities | -1,428 | -7,011 | 1,502 | 4,000 | 248.18 | 699.95 | Upgrade |
Other Investing Activities | 301.29 | 282.35 | 655.49 | 555.69 | 916.01 | 571.46 | Upgrade |
Investing Cash Flow | -1,939 | -7,545 | 1,290 | 2,537 | -3,668 | 1,166 | Upgrade |
Short-Term Debt Issued | - | - | - | - | 978 | - | Upgrade |
Long-Term Debt Issued | - | 2,400 | - | - | 3,900 | - | Upgrade |
Total Debt Issued | 2,400 | 2,400 | - | - | 4,878 | - | Upgrade |
Short-Term Debt Repaid | - | - | - | - | -978 | - | Upgrade |
Long-Term Debt Repaid | - | -4,130 | -192.75 | -176.33 | -267.41 | -227.56 | Upgrade |
Total Debt Repaid | -4,130 | -4,130 | -192.75 | -176.33 | -1,245 | -227.56 | Upgrade |
Net Debt Issued (Repaid) | -1,730 | -1,730 | -192.75 | -176.33 | 3,633 | -227.56 | Upgrade |
Financing Cash Flow | -2,728 | -1,730 | -192.75 | -176.33 | 3,633 | -227.56 | Upgrade |
Foreign Exchange Rate Adjustments | 44.95 | 1,422 | 284.86 | -24.31 | 397.42 | -233.22 | Upgrade |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | -0 | 0 | Upgrade |
Net Cash Flow | -1,009 | -4,788 | 4,231 | 4,559 | 498.31 | 740.79 | Upgrade |
Free Cash Flow | 3,119 | 2,808 | 1,970 | 220.98 | -3,171 | -60.76 | Upgrade |
Free Cash Flow Growth | 51.80% | 42.52% | 791.50% | - | - | - | Upgrade |
Free Cash Flow Margin | 18.16% | 17.79% | 12.95% | 1.61% | -26.96% | -0.76% | Upgrade |
Free Cash Flow Per Share | 218.48 | 195.26 | 137.01 | 15.37 | -220.57 | -5.84 | Upgrade |
Cash Interest Paid | 86.42 | 138.56 | 190.05 | 165.3 | 28.88 | 82.9 | Upgrade |
Cash Income Tax Paid | 127.43 | 122.89 | 169 | 49.25 | 113.39 | 8.65 | Upgrade |
Levered Free Cash Flow | 2,191 | 1,112 | 947.12 | -388.58 | -2,676 | 345.83 | Upgrade |
Unlevered Free Cash Flow | 2,236 | 1,217 | 1,081 | -284.86 | -2,658 | 397.6 | Upgrade |
Change in Working Capital | -733.47 | -932.52 | -1,649 | -1,677 | -4,526 | -947.48 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.